Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Barosense
company
About
BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.
- 11 - 50
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $27M
- Industries
- Biotechnology,Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$44.40M
Barosense has raised a total of
$44.40M
in funding over 2 rounds. Their latest funding was raised on
Aug 24, 2009 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 24, 2009 | Series D | $27M | 1 | — | — | Detail |
| Dec 5, 2007 | Series C | $11.20M | 1 | — | — | Detail |
| Dec 22, 2004 | Series B | $6.20M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
